IBD Plexus Publications
05/05/2025
Pediatric Risk
IDENTIFICATION OF EPIGENETIC FACTORS THAT INFLUENCE CROHN’S DISEASE DEVELOPMENT IN THOSE AT LOW GENETIC RISK FOR DISEASE
Digestive Disease Week
Abstract/Poster05/04/2025
SPARC IBD
DIFFERENTIAL ABUNDANCE OF THE FECAL METABOLOME BASED ON THE DISEASE PHENOTYPE OF A PATIENT WITH CROHN’S DISEASE: A COHORT ANALYSIS FROM THE STUDY OF PROSPECTIVE ADULT RESEARCH COHORT WITH IBD (SPARC IBD)
Digestive Disease Week
Abstract/Poster05/04/2025
SPARC IBD
ANALYZING PATIENT ENDOTYPES TO CHARACTERIZE HETEROGENEITY IN REAL-WORLD DATA FOR INFLAMMATORY BOWEL DISEASE
Digestive Disease Week
Abstract/Poster05/03/2025
SPARC IBD
REAL-WORLD OUTCOMES OF ADVANCED THERAPIES IN PERIANAL CROHN’S DISEASE: A COHORT ANALYSIS FROM THE STUDY OF PROSPECTIVE ADULT RESEARCH COHORT WITH INFLAMMATORY BOWEL DISEASE (SPARC IBD)
Digestive Disease Week
Abstract/Poster05/03/2025
SPARC IBD
ANTI-GRANULOCYTE MACROPHAGE-COLONY STIMULATING FACTOR AUTOANTIBODIES DEFINE A DISTINCT SUB-PHENOTYPE OF CROHN’S DISEASE
Gastroenterology
Abstract/Poster04/13/2025
SPARC IBD
Predicting ulcer in H&E images of inflammatory bowel disease using domain-knowledge-driven graph neural network
arXiv
Pre-Print04/04/2025
SPARC IBD
Tauroursodeoxycholic Acid (TUDCA) Reduces ER Stress and Lessens Disease Activity in Ulcerative Colitis
medRxiv
Pre-Print03/22/2025
SPARC IBD
Antigen-driven expansion of public clonal T cell populations in inflammatory bowel diseases
Journal of Crohn's and Colitis
Manuscript03/06/2025
Pediatric Risk
Early tumour necrosis factor antagonist treatment prevents perianal fistula development in children with Crohn's disease: post hoc analysis of the RISK study
Gut
Manuscript